Literature DB >> 27554797

Microbiota as a mediator of cancer progression and therapy.

Jillian L Pope1, Sarah Tomkovich2, Ye Yang1, Christian Jobin3.   

Abstract

Complex and intricate circuitries regulate cellular proliferation, survival, and growth, and alterations of this network through genetic and epigenetic events result in aberrant cellular behaviors, often leading to carcinogenesis. Although specific germline mutations have been recognized as cancer inducers, the vast majority of neoplastic changes in humans occur through environmental exposure, lifestyle, and diet. An emerging concept in cancer biology implicates the microbiota as a powerful environmental factor modulating the carcinogenic process. For example, the intestinal microbiota influences cancer development or therapeutic responses through specific activities (immune responses, metabolites, microbial structures, and toxins). The numerous effects of microbiota on carcinogenesis, ranging from promoting, preventing, or even influencing therapeutic outcomes, highlight the complex relationship between the biota and the host. In this review, we discuss the latest findings on this complex microbial interaction with the host and highlight potential mechanisms by which the microbiota mediates such a wide impact on carcinogenesis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27554797      PMCID: PMC5674984          DOI: 10.1016/j.trsl.2016.07.021

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  121 in total

Review 1.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

2.  Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?

Authors:  Antoaneta Belcheva; Thergiory Irrazabal; Alberto Martin
Journal:  Bioessays       Date:  2015-01-20       Impact factor: 4.345

3.  Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth.

Authors:  Jonathan Lévy; Wulfran Cacheux; Medhi Ait Bara; Antoine L'Hermitte; Patricia Lepage; Marie Fraudeau; Coralie Trentesaux; Julie Lemarchand; Aurélie Durand; Anne-Marie Crain; Carmen Marchiol; Gilles Renault; Florent Dumont; Franck Letourneur; Myriam Delacre; Alain Schmitt; Benoit Terris; Christine Perret; Mathias Chamaillard; Jean-Pierre Couty; Béatrice Romagnolo
Journal:  Nat Cell Biol       Date:  2015-07-27       Impact factor: 28.824

4.  Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

Authors:  Marie Vétizou; Jonathan M Pitt; Romain Daillère; Patricia Lepage; Nadine Waldschmitt; Caroline Flament; Sylvie Rusakiewicz; Bertrand Routy; Maria P Roberti; Connie P M Duong; Vichnou Poirier-Colame; Antoine Roux; Sonia Becharef; Silvia Formenti; Encouse Golden; Sascha Cording; Gerard Eberl; Andreas Schlitzer; Florent Ginhoux; Sridhar Mani; Takahiro Yamazaki; Nicolas Jacquelot; David P Enot; Marion Bérard; Jérôme Nigou; Paule Opolon; Alexander Eggermont; Paul-Louis Woerther; Elisabeth Chachaty; Nathalie Chaput; Caroline Robert; Christina Mateus; Guido Kroemer; Didier Raoult; Ivo Gomperts Boneca; Franck Carbonnel; Mathias Chamaillard; Laurence Zitvogel
Journal:  Science       Date:  2015-11-05       Impact factor: 47.728

Review 5.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

6.  A crypt-specific core microbiota resides in the mouse colon.

Authors:  Thierry Pédron; Céline Mulet; Catherine Dauga; Lionel Frangeul; Christian Chervaux; Gianfranco Grompone; Philippe J Sansonetti
Journal:  mBio       Date:  2012-05-22       Impact factor: 7.867

7.  Potential of fecal microbiota for early-stage detection of colorectal cancer.

Authors:  Georg Zeller; Julien Tap; Anita Y Voigt; Shinichi Sunagawa; Jens Roat Kultima; Paul I Costea; Aurélien Amiot; Jürgen Böhm; Francesco Brunetti; Nina Habermann; Rajna Hercog; Moritz Koch; Alain Luciani; Daniel R Mende; Martin A Schneider; Petra Schrotz-King; Christophe Tournigand; Jeanne Tran Van Nhieu; Takuji Yamada; Jürgen Zimmermann; Vladimir Benes; Matthias Kloor; Cornelia M Ulrich; Magnus von Knebel Doeberitz; Iradj Sobhani; Peer Bork
Journal:  Mol Syst Biol       Date:  2014-11-28       Impact factor: 11.429

8.  Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.

Authors:  Bret D Wallace; Adam B Roberts; Rebecca M Pollet; James D Ingle; Kristen A Biernat; Samuel J Pellock; Madhu Kumar Venkatesh; Leah Guthrie; Sara K O'Neal; Sara J Robinson; Makani Dollinger; Esteban Figueroa; Sarah R McShane; Rachel D Cohen; Jian Jin; Stephen V Frye; William C Zamboni; Charles Pepe-Ranney; Sridhar Mani; Libusha Kelly; Matthew R Redinbo
Journal:  Chem Biol       Date:  2015-09-10

9.  Fat, fibre and cancer risk in African Americans and rural Africans.

Authors:  Stephen J D O'Keefe; Jia V Li; Leo Lahti; Junhai Ou; Franck Carbonero; Khaled Mohammed; Joram M Posma; James Kinross; Elaine Wahl; Elizabeth Ruder; Kishore Vipperla; Vasudevan Naidoo; Lungile Mtshali; Sebastian Tims; Philippe G B Puylaert; James DeLany; Alyssa Krasinskas; Ann C Benefiel; Hatem O Kaseb; Keith Newton; Jeremy K Nicholson; Willem M de Vos; H Rex Gaskins; Erwin G Zoetendal
Journal:  Nat Commun       Date:  2015-04-28       Impact factor: 14.919

10.  Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice.

Authors:  Laure B Bindels; Audrey M Neyrinck; Nuria Salazar; Bernard Taminiau; Céline Druart; Giulio G Muccioli; Emmanuelle François; Christophe Blecker; Aurore Richel; Georges Daube; Jacques Mahillon; Clara G de los Reyes-Gavilán; Patrice D Cani; Nathalie M Delzenne
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

View more
  19 in total

1.  Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.

Authors:  Sarah Tomkovich; Ye Yang; Kathryn Winglee; Josee Gauthier; Marcus Mühlbauer; Xiaolun Sun; Mansour Mohamadzadeh; Xiuli Liu; Patricia Martin; Gary P Wang; Eric Oswald; Anthony A Fodor; Christian Jobin
Journal:  Cancer Res       Date:  2017-04-17       Impact factor: 12.701

2.  A New Approach to Testing Mediation of the Microbiome at Both the Community and Individual Taxon Levels.

Authors:  Ye Yue; Yi-Juan Hu
Journal:  Bioinformatics       Date:  2022-05-05       Impact factor: 6.931

3.  The human tumor microbiome is composed of tumor type-specific intracellular bacteria.

Authors:  Deborah Nejman; Ilana Livyatan; Garold Fuks; Noam Shental; Ravid Straussman; Nancy Gavert; Yaara Zwang; Leore T Geller; Aviva Rotter-Maskowitz; Roi Weiser; Giuseppe Mallel; Elinor Gigi; Arnon Meltser; Gavin M Douglas; Iris Kamer; Vancheswaran Gopalakrishnan; Tali Dadosh; Smadar Levin-Zaidman; Sofia Avnet; Tehila Atlan; Zachary A Cooper; Reetakshi Arora; Alexandria P Cogdill; Md Abdul Wadud Khan; Gabriel Ologun; Yuval Bussi; Adina Weinberger; Maya Lotan-Pompan; Ofra Golani; Gili Perry; Merav Rokah; Keren Bahar-Shany; Elisa A Rozeman; Christian U Blank; Anat Ronai; Ron Shaoul; Amnon Amit; Tatiana Dorfman; Ran Kremer; Zvi R Cohen; Sagi Harnof; Tali Siegal; Einav Yehuda-Shnaidman; Einav Nili Gal-Yam; Hagit Shapira; Nicola Baldini; Morgan G I Langille; Alon Ben-Nun; Bella Kaufman; Aviram Nissan; Talia Golan; Maya Dadiani; Keren Levanon; Jair Bar; Shlomit Yust-Katz; Iris Barshack; Daniel S Peeper; Dan J Raz; Eran Segal; Jennifer A Wargo; Judith Sandbank
Journal:  Science       Date:  2020-05-29       Impact factor: 47.728

4.  Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0.

Authors:  R Aarnoutse; J M P G M de Vos-Geelen; J Penders; E G Boerma; F A R M Warmerdam; B Goorts; S W M Olde Damink; Z Soons; S S M Rensen; M L Smidt
Journal:  Int J Colorectal Dis       Date:  2017-04-25       Impact factor: 2.571

Review 5.  Significance of Streptococcus gallolyticus subsp. gallolyticus Association With Colorectal Cancer.

Authors:  Ewa Pasquereau-Kotula; Mariana Martins; Laetitia Aymeric; Shaynoor Dramsi
Journal:  Front Microbiol       Date:  2018-04-03       Impact factor: 5.640

Review 6.  Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.

Authors:  Concetta Panebianco; Angelo Andriulli; Valerio Pazienza
Journal:  Microbiome       Date:  2018-05-22       Impact factor: 14.650

7.  Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice.

Authors:  Masanori Horie; Takamasa Miura; Satomi Hirakata; Akira Hosoyama; Sakiko Sugino; Aya Umeno; Kazutoshi Murotomi; Yasukazu Yoshida; Taisuke Koike
Journal:  Exp Anim       Date:  2017-07-12

Review 8.  Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development.

Authors:  Melvin Kantono; Beichu Guo
Journal:  Front Immunol       Date:  2017-09-12       Impact factor: 7.561

9.  Combination Therapy of TGF-β Blockade and Commensal-derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression.

Authors:  Linlin Shi; Jianyong Sheng; Mengli Wang; Han Luo; Jun Zhu; Bixiang Zhang; Zhi Liu; Xiangliang Yang
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

10.  A Customized At-Home Stool Collection Protocol for Use in Microbiome Studies Conducted in Cancer Patient Populations.

Authors:  Stephanie R Hogue; Maria F Gomez; Wildson Vieira da Silva; Christine M Pierce
Journal:  Microb Ecol       Date:  2019-03-30       Impact factor: 4.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.